When romiplostim might be reasonable

John Bazar considers using romiplostim in curative settings but emphasizes need for trials linking dose intensity to outcomes.

Play episode from 12:03

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!